Constraint-induced Movement Therapy for Perinatal Brachial Plexus Injury
NCT ID: NCT03765034
Last Updated: 2018-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2010-01-01
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Armeo Spring Pediatric in Obstetric Brachial Plexus Injury
NCT03780322
Brachial Plexus Birth Palsy: Reinforcement Paradigm to Augment Recovery
NCT03886792
Modified Constraint Induced Movement Therapy in Children With Obstetric Brachial Plexus Injury
NCT05411731
Reanimation of Shoulder External Rotation Via Neurotization
NCT06787391
Combined Constraint Therapy and Bimanual Therapy for Children With Unilateral Brain Injury
NCT02840643
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Constraint-induced movement therapy (CIMT) is known to increase upper extremity function in children with weakness or disuse as a result of cerebral palsy. However, it is unknown if this therapy is effective for treating arm weakness or disuse as a result of perinatal brachial plexus injury. The addition of CIMT to usual and standard occupational therapy care is evaluated in this trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Constraint-induced Movement Therapy
A passive constraint cast is applied to the participant's unaffected arm to prevent use for 8 weeks.
Constrain-induced Movement Therapy
8-week therapy program utilizing constraint of the unaffected arm
Usual Occupational Therapy
8-week therapy program without constraint of the unaffected arm
Usual Occupational Therapy
Usual and standard care occupational therapy is administered for 8 weeks.
Usual Occupational Therapy
8-week therapy program without constraint of the unaffected arm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Constrain-induced Movement Therapy
8-week therapy program utilizing constraint of the unaffected arm
Usual Occupational Therapy
8-week therapy program without constraint of the unaffected arm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant walking at time of study inception
* Ability to cooperate with interventions and assessment
* Participant currently receiving occupational therapy 1+ hour per week and planning to continue for duration of study
Exclusion Criteria
* Flaccidity of the involved upper extremity or no observable hand function
* Planned surgery or drug intervention during the study period
* Allergy or intolerance to constraint intervention materials
12 Months
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
julie werner
Clinical Scientist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCI-10-00255
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.